Successful TAVI case using the BAV as bridge to TAVI in ...

Post on 08-Nov-2021

8 views 0 download

Transcript of Successful TAVI case using the BAV as bridge to TAVI in ...

Successful TAVI case using the BAV as bridge to TAVI in severe AS patient with very high risk

Sejong General HospitalCheol Woong Yu, MD, PhD

2010 Sejong Cardiovascular Symposium

Case 1• M/68• CC: DOE Fc III~IV (onset; 1 months ) and

cardiogenic shock, altered mentality.• P.I.; He was undergoing HF therapy due to

severe AS at other hospital but transferred to our hospital because of aggravation of HF and unstable condition.

• P/Hx; HTN, CHF (since 1 year ago), heavy alcoholics

• No prev cardiac surgery, No bypassed vessel

2010 Sejong Cardiovascular Symposium

Lab findings

• V/S BP 80/55, RR 32, • Renal function: Ccr 30ml/min (B/Cr

98/2.55)• AST/ALT 1879/1777, TB 2.7, uric acid;22.8• INR 2.09• Troponin T;0.299, ProBNP;33325, CK-

MB;31.9• ABGA;PH 7.456-PCO2 20.6-PO2 101.6- BE -

6.6• CBC;WBC 19.5 Hg 12.9(MCV74.4, MCH

25.4)-Plt 197K

2010 Sejong Cardiovascular Symposium

Chest X ray

2010 Sejong Cardiovascular Symposium

Transthoracic Echocardiography

2010 Sejong Cardiovascular Symposium

Transthoracic Echocardiography

Moderate to severe LV systolic dysfunctionModerate MR, LVE, LAE,

2010 Sejong Cardiovascular Symposium

Transthoracic Echocardiography

• LV 68/58mm, EF 31%, AVA=0.7cm2 by CE• AV peak/mean PG=93/63mmHg

2010 Sejong Cardiovascular Symposium

Very high risk patient

• Severe AS with severe LV systolic dysfx, mod MR

• CHF with pul edema, • cardiogenic shock• ARF on CKD• Congestive hepatopathy• LC(?)

• Logistic Euroscore; 74% STS; 18%

2010 Sejong Cardiovascular Symposium

The next day…

• The patient was more aggravated..

• -> BP 70/40..and anuria, azotemia, mental change despite of use of all inotropics

What should I do at this situation?

2010 Sejong Cardiovascular Symposium

Can the BAV be troubleshooter for this crucial moment?

Z-med 22x30mm,superstiff Amplatz 035 wire, 4atm

2010 Sejong Cardiovascular Symposium

Can the BAV be troubleshooter for this crucial moment?

2010 Sejong Cardiovascular Symposium

Hemodynamic tracing during BAV

2010 Sejong Cardiovascular Symposium

Post BAV TTE• LV 70/53mm, EF 40% (<-30%), AVA=1.1cm2 (<-0.7)• AV peak/mean PG=99/63mmHg•(<- 93/63mmHg)• Mod to severe AR

2010 Sejong Cardiovascular Symposium

PostBAV course…

• V/S stable, 80~60/40~55 -> 120/70• Mental alert• CRRT apply-> azotemia improved• LFT improved

3 days later, sudden cardiac arrest developed and the patient died !!

2010 Sejong Cardiovascular Symposium

Case 2• M/77• CC: DOE Fc III~IV (onset; 2 months )• P.I.; He was undergoing TACE therapy due to

HCC at other hospital and developed CHF during that therapy. So, he was transferred to our hospital because of aggravation of HF after diagnosis of severe AS

• P/Hx; HTN, DM, recent stroke, HCC (7 times TACE) , radiation pneumonitis(?)

• NO prev cardiac surgery, No bypassed vessel

2010 Sejong Cardiovascular Symposium

Lab findings

• V/S BP 131/63, RR 42 • Renal function: normal• LFT;normal• PFT; mild obstructive lung disease• ABGA;PH 7.457-PCO2 38.5-PO2 61.6- BE 4.0• CBC;WBC 4860 Hg 11.1(MCV 98.0, MCH

33.2)-Plt 189K

2010 Sejong Cardiovascular Symposium

Chest X ray and EKG

A.Fib with complete AV block

2010 Sejong Cardiovascular Symposium

TTEAVA=0.74/0.6 by CE/Planimetry, Peak/Mean PG=129/71 mmHgPeak V;5.7m/s, EF=79%, mild to mod AR, MR, TR, PA pr;58mmHg

2010 Sejong Cardiovascular Symposium

What is the next step ?..

Permanent pacemaker implantation

After PM implantation , the patient continuely complained of dyspnea and orthopnea…

BAV..?

2010 Sejong Cardiovascular Symposium

BAV…

TYSHAK 23x30mm, Amplatzer superstiff 035x26020% contrast, 2 atm x3

2010 Sejong Cardiovascular Symposium

Hemodynamic tracing between pre and post BAV

Mean PG: 83 -> 51mmHg

2010 Sejong Cardiovascular Symposium

Post BAV TTEAVA=0.95cm2 (<-0.74), Peak/Mean PG=101/59 mmHg(<-129/71)Peak V;5m/s, EF=79%, mild AR , MR, TR, PA pr;73mmHg

2010 Sejong Cardiovascular Symposium

Post BAV clinical course..

Pleural effusion remained but symptomatically stable

2010 Sejong Cardiovascular Symposium

2 weeks after BAV, TAVI was safely performed

AP Caudal 11.2 Ascendra balloon 26mm

2010 Sejong Cardiovascular Symposium

2 weeks after BAV, TAVI was safely performed

Edwards SAPIEN THV 26mm TEE finding; optimal implantation

2010 Sejong Cardiovascular Symposium

Post TAVI TEE

2010 Sejong Cardiovascular Symposium

Post TAVI TTEAV peak/mean PG=17.5/9.5mmHg

2010 Sejong Cardiovascular Symposium

Post TAVI clinical course

No further pleural effusion V/S stableNo orthopnea, N dyspneaImproved functional capacity

Take home message

•BAV can play an important role, such as bridge to TAVI, especially in very high risk patient.

•To achieve optimal BAV result as a bridge role and to avoid complication associated with BAV procedure, further studies is needed , such as about optimal balloon size, inflation pressure, postBAV pr gradient, and so on.